Antero Midstream Co. (NYSE:AM – Free Report) – Equities researchers at Zacks Research dropped their Q1 2025 earnings per share estimates for shares of Antero Midstream in a research report issued to clients and investors on Monday, November 25th. Zacks Research analyst R. Department now anticipates that the pipeline company will post earnings of $0.23 per share for the quarter, down from their prior estimate of $0.24. The consensus estimate for Antero Midstream’s current full-year earnings is $0.83 per share.
AM has been the topic of several other research reports. Morgan Stanley upped their price objective on Antero Midstream from $15.00 to $16.00 and gave the company an “underweight” rating in a research note on Tuesday, August 27th. StockNews.com downgraded Antero Midstream from a “buy” rating to a “hold” rating in a research note on Monday, August 5th.
Antero Midstream Stock Performance
AM stock opened at $15.77 on Wednesday. The firm has a market cap of $7.59 billion, a PE ratio of 19.62 and a beta of 2.35. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.49. The business has a 50 day moving average of $15.22 and a 200-day moving average of $14.78. Antero Midstream has a 12-month low of $11.58 and a 12-month high of $15.90.
Antero Midstream Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 6th. Stockholders of record on Wednesday, October 23rd were issued a $0.225 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $0.90 annualized dividend and a dividend yield of 5.71%. Antero Midstream’s payout ratio is currently 111.11%.
Insider Transactions at Antero Midstream
In related news, Director Brooks J. Klimley sold 10,000 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $14.66, for a total value of $146,600.00. Following the transaction, the director now owns 74,100 shares of the company’s stock, valued at $1,086,306. This represents a 11.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.61% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new position in shares of Antero Midstream during the third quarter valued at about $38,000. Blue Trust Inc. grew its stake in shares of Antero Midstream by 149.4% during the third quarter. Blue Trust Inc. now owns 3,100 shares of the pipeline company’s stock valued at $46,000 after buying an additional 1,857 shares during the last quarter. Brooklyn Investment Group bought a new position in shares of Antero Midstream during the third quarter valued at about $48,000. City State Bank bought a new position in shares of Antero Midstream during the second quarter valued at about $51,000. Finally, First Horizon Advisors Inc. grew its stake in shares of Antero Midstream by 24.2% during the second quarter. First Horizon Advisors Inc. now owns 3,528 shares of the pipeline company’s stock valued at $52,000 after buying an additional 688 shares during the last quarter. Institutional investors own 53.97% of the company’s stock.
Antero Midstream Company Profile
Antero Midstream Corporation owns, operates, and develops midstream energy assets in the Appalachian Basin. It operates in two segments, Gathering and Processing, and Water Handling. The Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collects and processes production from Antero Resources' wells in West Virginia and Ohio.
Read More
- Five stocks we like better than Antero Midstream
- Energy and Oil Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Calculate Stock Profit
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Insider Trades May Not Tell You What You Think
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Antero Midstream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antero Midstream and related companies with MarketBeat.com's FREE daily email newsletter.